There are at least 4.7 million people between the ages of 65 and 85 with moderate or greater valvular heart disease (VHD) in the United States.
Mesenchymal stem cells (MSCs) are adult stem cells that originate from the mesenchymal and connective tissue of the bone marrow, adipose tissue, placenta, umbilical cord, cord blood, peripheral blood, ...
SEATTLE, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), today announced the appointment of Claudia Lopez, DVM, MSc, as its new Vice President, ...
This blended learning programme integrates academic knowledge and understanding of perfusion science with both the needs of the working professional clinical perfusion scientist and the demands of ...
CD19 chimeric antigen receptor T-cell therapy improved lung function and skin thickness in patients with severe refractory ...
Unlock the advantage of pragmatic trials and improve efficiency and real-world relevance to reduce risk and strengthen ...
Ayodeji Adegunsoye, MD, PhD, MSc, highlights how the underrepresentation of minority populations in pulmonary fibrosis genetic studies hinders accurate disease risk prediction and broader clinical ...
Human mesenchymal stem cells (MSCs) hold great promise for clinical use and cell therapy applications. To ensure highest quality and safety of the resulting cellular products, MSCs have to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback